Forest Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.02.14	Forest Labs To Discontinue Sale Of NAMENDA Tablets Effective Aug. 15, 2014 (RTTNews)
03.02.14	Forest Laboratories Closes $2.9 Bln. Acquisition Of Aptalis (RTTNews)
03.02.14	Forest Labs Fights Back, VNDA Gets Thumbs Up From FDA, IntelGenx Awaits Decision (RTTNews)
31.01.14	Forest Labs Sues Several Companies For Infringement Of NAMENDA XR Patents (RTTNews)
28.01.14	Forest Laboratories, Inc. -- Moody's rates Forest Lab's new senior notes Ba1 (Moodys)
28.01.14	Forest LabS Prices Offering Of $1.8 Bln In Senior Notes - Quick Facts (RTTNews)
21.01.14	Pre-market Movers For Jan 21 (VZ, BBRY, YRCW, FRX, SAP, PATH, CNBC, CNOB) (RTTNews)
21.01.14	Forest Labs Posts Profit In Q3 Above View; Raises FY14 Earnings Forecast (RTTNews)
21.01.14	Forest Labs Q3 Profit Beats View; Lifts FY14 Forecast - Quick Facts (RTTNews)
21.01.14	Earnings Watch For January 21(JNJ, TRV, VZ, AMD, IBM, TXN) (RTTNews)
09.01.14	Trevena Initiates Dosing In Phase 2b BLAST-AHF Trial Of TRV027 For AHF Patients (RTTNews)
08.01.14	ROUNDUP/Aktien New York Schluss: Dow leicht im Minus nach Arbeitsmarktdaten (dpa-afx)
08.01.14	Aptalis Pharma Inc. -- Moody's reviews Aptalis Pharma ratings for upgrade (Moodys)
08.01.14	Aktien New York: Dow leicht im Minus - Arbeitsmarktdaten negativ aufgenommen (dpa-afx)
08.01.14	Forest Laboratories, Inc. -- Moody's affirms Forest Labs' Ba1 rating on Aptalis deal (Moodys)
08.01.14	ROUNDUP/Aktien New York: Dow leicht im Minus nach Arbeitsmarktdaten (dpa-afx)
08.01.14	Forest Labs To Buy Privately-held Aptalis For $2.9 Bln Cash (RTTNews)
08.01.14	Aktien New York Ausblick: Dow kaum verändert erwartet nach Arbeitsmarktdaten (dpa-afx)
08.01.14	Milliardenübernahme in US-Pharmabranche (dpa-afx)
08.01.14	Milliardenübernahme in US-Pharmabranche (AWP)
08.01.14	Forest Labs. To Acquire Privately-held Aptalis For $2.9 Bln Cash - Quick Facts (RTTNews)
08.01.14	Reports: Forest Laboratories Close To $3 Bln Deal For Aptalis (RTTNews)
09.12.13	Forest Labs Announces Various Executive Appointments; Frank Perier Jr. Named CFO (RTTNews)
03.12.13	ACRX At FDA Altar, Orphan Drug Status Lifts CNAT, LCI Moves To NYSE (RTTNews)
02.12.13	Forest Laboratories, Inc. -- Moody's assigns Ba1 rating to Forest Labs (Moodys)
02.12.13	Forest Laboratories To Buy Exclusive Rights For Saphris From Merck Sharp & Dohme (RTTNews)
21.11.13	Forest Labs Gets Complete Response Letter For Cariprazine; Addl. Data Sought (RTTNews)
22.10.13	Forest Labs Q2 Results Beat Estimates, Lifts FY14 View (RTTNews)
22.10.13	Pre-market Movers For Oct 22 (WHR, TRV, SYMM, NFLX, NUS, FRX, LMT, MDVN, PTIE) (RTTNews)
22.10.13	Forest Labs. Q2 Profit Soars; Revises FY14 Adj. EPS View - Quick Facts (RTTNews)
22.10.13	Earnings Watch For October 22 (UTX, TRV, JNPR, AMGN, KMB,DD) (RTTNews)
09.10.13	Pre-Market Review: Celgene Corp., Forest Laboratories Inc., Peregrine Pharma Inc., and Edwards Lifesciences Corp. (PR Newswire)
30.09.13	Product Launches, Clinical Study Results, Historical Trials, Joint Lawsuits and Milestone Patient Enrollment - Research Report on Teva, Pacira, Novo Nordisk, Forest, and Amarin (PR Newswire)
17.09.13	Trevena Names Roberto Cuca SVP, CFO - Quick Facts (RTTNews)
17.09.13	Trevena Appoints Roberto Cuca as Senior Vice President & Chief Financial Officer (PR Newswire)
17.09.13	Clinical Trial Updates, Appointments, FDA Acknowledgments and Qualifications - Research Report on Novartis, Endo, The Medicines Company, United Therapeutics, and Forest (PR Newswire)
13.09.13	Forest Labs' Ceftazidime/avibactam Combination Gets QIDP Designation From FDA (RTTNews)
10.09.13	Forest Laboratories Names Director Brent Saunders As President, CEO (RTTNews)
10.09.13	Forest Labs. Names Brenton Saunders CEO And President - Quick Facts (RTTNews)
06.09.13	Early Briefing and Review: Celgene Corp., Edwards Lifesciences Corp., Forest Laboratories Inc., and Peregrine Pharma Inc. (PR Newswire)
02.09.13	Acquisitions, NDA Filings, Key Findings, Conferences and Product Launches - Research Report on Perrigo, Forest Labs, Avanir Pharmaceuticals, Cubist Pharmaceuticals, and Dr. Reddy's Laboratories (PR Newswire)
15.08.13	SPRING Makes AMPE Jump, AVNR Buys Peace, FRX Delays NDA Submission (RTTNews)
14.08.13	Forest Labs, Almirall Delay NDA Filing For Aclidinium/formoterol Combination (RTTNews)
31.07.13	Morning Research: Celgene, Edwards Lifesciences, Forest Laboratories, and Peregrine Pharma (PR Newswire)
30.07.13	Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study (PR Newswire)
29.07.13	Seeking Growth Opportunities through Understanding Market Trends, Strengthened R&D, and Global Expansion - Research Report on WellPoint, Thermo Fisher, Varian, Medicines Co., and Forest Laboratories (PR Newswire)
23.07.13	Forest Labs. Q1 Profit Falls, Adj. EPS Flat - Quick Facts (RTTNews)
23.07.13	Earnings Watch For July 23 (DD, AAPL, T, EA, JNPR, UPS, VMW) (RTTNews)
22.07.13	Forest Labs Announces Additional Settlement Agreement In BYSTOLIC Patent Dispute (RTTNews)
16.10.12	Forest Laboratories: Gewinn im zweiten Quartal bricht ein (Aktiencheck)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	545.60	2.17 %	K V
Sika	235.80	1.51 %	K V
CieFinRichemont	127.65	1.43 %	K V
Part Grp Hldg	1’299.50	1.33 %	K V
Holcim	91.86	1.15 %	K V
Roche Hldg G	254.50	-0.66 %	K V
Lonza Grp	525.00	-0.72 %	K V
Sonova Hldg	297.70	-1.03 %	K V
Alcon	77.12	-1.20 %	K V
Swiss Life Hldg	690.40	-4.69 %	K V

mehr

17:58		STOXX-Handel: STOXX 50 zum Handelsende im Aufwind
17:58		FTSE 100 aktuell: FTSE 100 verbucht schlussendlich Zuschläge
16:02		S&P 500-Titel Pfizer-Aktie: So viel hätte eine Investition in Pfizer von vor 3 Jahren gekostet
15:58		Gute Stimmung in Europa: STOXX 50 am Dienstagnachmittag im Plus
15:58		Aufschläge in London: FTSE 100 am Dienstagnachmittag in Grün
12:26		Pluszeichen in London: FTSE 100 im Aufwind
09:28		FTSE 100 aktuell: Zum Start Pluszeichen im FTSE 100
02.12.24		Handel in Europa: STOXX 50 verbucht schlussendlich Zuschläge

17:58

STOXX-Handel: STOXX 50 zum Handelsende im Aufwind

17:58

FTSE 100 aktuell: FTSE 100 verbucht schlussendlich Zuschläge

16:02

S&P 500-Titel Pfizer-Aktie: So viel hätte eine Investition in Pfizer von vor 3 Jahren gekostet

15:58

Gute Stimmung in Europa: STOXX 50 am Dienstagnachmittag im Plus

15:58

Aufschläge in London: FTSE 100 am Dienstagnachmittag in Grün

12:26

Pluszeichen in London: FTSE 100 im Aufwind